Clinical investigationLow-dosage dobutamine magnetic resonance imaging as an alternative to echocardiography in the detection of viable myocardium after acute infarction
References (22)
- et al.
Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography
J Am Coll Cardiol
(1990) - et al.
Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphologically abnormal left ventricle
Am Heart J
(1990) - et al.
Distinguishing viable from infarcted myocardium after experimental ischemia and reperfusion using nuclear magnetic resonance imaging
J Am Coll Cardiol
(1990) - et al.
Detection, characterization and functional assessment of reperfused Q-wave acute myocardial infarction by cine magnetic resonance imaging
Am J Cardiol
(1990) - et al.
Dobutamine stress nuclear magnetic resonance imaging for the detection of coronary disease
J Am Coll Cardiol
(1993) Myocardial ‘stunning’ in man
Circulation
(1992)- et al.
The stunned myocardium: prolonged postischemic ventricular dysfunction
Circulation
(1982) - et al.
Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium
Circulation
(1993) - et al.
Low dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction
Circulation
(1993) - et al.
Wanted dead or alive: assessment of myocardial viability after thrombolysis
Circulation
(1993)
Determination of left ventricular mass by magnetic resonance imaging in hearts deformed by acute infarction
Circulation
Cited by (80)
Role of Cardiovascular Magnetic Resonance in Ischemic Cardiomyopathy
2021, Heart Failure ClinicsCitation Excerpt :The primary technique consists of stress testing (with various stressor agents) and assessment of myocardial viability by delayed gadolinium enhancement or late gadolinium enhancement (LGE) imaging. Stress CMR has been used since 19871 to diagnose myocardial ischemia,2 quantify myocardial contractile reserve,3 and identify patients at risk for adverse cardiovascular outcomes.4 Stress CMR relies on the principle of detecting wall motion abnormalities (WMAs) provoked by a primary stress agent (dobutamine) and the single-photon emission computed tomography (SPECT) principle of detecting perfusion defects with administration of a vasodilator (adenosine/regadenoson or dipyridamole).
Stress Cardiovascular Magnetic Resonance: Wall Motion
2018, Cardiovascular Magnetic Resonance: A Companion to Braunwald’s Heart DiseaseAssessment of Cardiac Function
2018, Cardiovascular Magnetic Resonance: A Companion to Braunwald’s Heart DiseaseEvaluation of Myocardial Viability With Cardiac Magnetic Resonance Imaging
2011, Progress in Cardiovascular DiseasesVentricular response to stress predicts outcome in adult patients with a systemic right ventricle
2010, American Heart JournalCitation Excerpt :The diagnostic and prognostic value of stress CMR in patients with acquired heart disease has already been established. Dobutamine stress CMR has been proven useful to detect myocardial ischemia in patients with chest pain,14-17 and to predict future myocardial infarction and cardiac death in patients with coronary artery disease.18,19 Moreover, in patients with mildly to moderately reduced left ventricular ejection fraction stress CMR is prognostic for future myocardial infarction and cardiac death.20
The 20 year evolution of dobutamine stress cardiovascular magnetic resonance
2010, Journal of Cardiovascular Magnetic Resonance